Molecular Basis of Disease Pathogenesis

The molecular basis of disease pathogenesis is the study of how alterations at the level of genes, proteins, and signalling pathways give rise to the structural and functional abnormalities that define disease. It links the molecular lesion (a mutation, an epigenetic change, an aberrant protein) to the cellular and tissue-level phenotype that pathologists and clinicians observe, and it provides the conceptual foundation for molecular pathology.

Definition

Molecular pathogenesis is the chain of molecular events — from a causative genetic or epigenetic alteration, through perturbed protein function and signalling, to the cellular dysfunction and tissue change that constitute disease.

Scope

This area orients the reader to the major molecular themes that recur across human disease: the genes whose gain or loss drives cancer, the genome-maintenance systems whose failure produces genetic instability, the regulatory and epigenetic mechanisms that control gene expression, and the inherited single-gene and cancer-predisposition syndromes that reveal pathogenic mechanisms with particular clarity. It is a reference overview; the detailed treatment lives in the constituent topics.

Sub-topics

• Gene Expression Regulation and Epigenetics in Disease
• Genetic Instability and DNA Repair Genes
• Hereditary Cancer Syndromes: Molecular Basis
• Oncogenes and Tumor Suppressor Genes
• Single-Gene Disorders and Pathogenic Mechanisms

Core questions

• How does a molecular lesion in a gene or protein translate into a disease phenotype?
• Which classes of molecular change (oncogene activation, tumour-suppressor loss, genomic instability, epigenetic dysregulation) recur across disease?
• How do inherited mutations differ from acquired (somatic) ones in their pathogenic consequences?
• How does understanding the molecular mechanism inform classification and biomarker discovery?

Key concepts

• Driver versus passenger mutations
• Germline versus somatic alteration
• Genotype-phenotype relationship
• Loss-of-function and gain-of-function lesions
• Signalling pathway dysregulation
• Molecular classification of disease

Key theories

Hallmarks of cancer

Hanahan and Weinberg proposed that the diverse genotypes of cancer cells converge on a small set of acquired functional capabilities — sustained proliferative signalling, evasion of growth suppressors, resistance to cell death, replicative immortality, angiogenesis, and invasion/metastasis — providing an organising framework for the molecular pathogenesis of malignancy.

Somatic mutation and cancer genome landscapes

Large-scale sequencing reframed cancer as a disease of the genome in which a relatively small number of 'driver' alterations among many 'passenger' changes confer selective growth advantage, distinguishing the mutations that cause disease from incidental ones.

Mechanisms

Disease arises when a molecular alteration changes the amount, structure, or regulation of a gene product in a way that perturbs cellular function. Activating changes in proto-oncogenes and inactivating changes in tumour-suppressor genes drive uncontrolled proliferation; failure of DNA-repair and genome-maintenance systems accelerates the accumulation of such changes; epigenetic dysregulation silences or activates genes without altering sequence; and inherited mutations can predispose to disease across whole tissues. Across these routes, the common principle is that a definable molecular lesion is propagated through signalling networks to produce the cellular and tissue phenotype recognised as disease.

Clinical relevance

Understanding molecular pathogenesis underlies the molecular classification of tumours and inherited disorders, the rational selection of biomarkers, and the interpretation of genetic testing in pathology and laboratory medicine. This entry describes how molecular mechanisms generate disease phenotypes for educational and reference purposes; it is not a guide to diagnosis or treatment of any individual.

History

Molecular pathology emerged as the techniques of molecular biology — recombinant DNA, sequencing, and later high-throughput genomics — were brought to bear on the long-standing pathological project of explaining disease. The articulation of the hallmarks of cancer (2000, updated 2011) and the mapping of cancer genome landscapes (2013) consolidated a mechanism-centred view of pathogenesis that now spans oncology and inherited disease alike.

Key figures

• Robert Weinberg
• Douglas Hanahan
• Bert Vogelstein
• Kenneth Kinzler

Seminal works

• hanahan-weinberg-2000
• hanahan-weinberg-2011
• vogelstein-2013

Frequently asked questions

What does 'molecular basis of disease' mean?

It refers to the underlying genetic, epigenetic, and protein-level changes that cause the cellular and tissue abnormalities seen in a disease, connecting a molecular lesion to the observed phenotype.

How is a germline mutation different from a somatic mutation?

A germline mutation is inherited and present in every cell, so it can predispose an entire individual to disease, whereas a somatic mutation is acquired in particular cells during life and is confined to their descendants.